Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (81-90 of 282) with videos related to

Pageof 29
Sort By:
Blood|January 15, 1998
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantationL H Sehn, J H Antin, L N Shulman, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
Oral chemotherapy safety practices at US cancer centres: questionnaire surveySaul N Weingart, Jonathan Flug, Daniela Brouillard, et al.
Journal of the National Cancer Institute|January 1, 2013
Tumor boards and the quality of cancer careNancy L Keating, Mary Beth Landrum, Elizabeth B Lamont, et al.
The American Journal of Medicine|April 1, 1990
Hemostatic complications in young patients with essential thrombocythemiaA J Mitus, T Barbui, L N Shulman, et al.
JNCI Cancer Spectrum|April 25, 2026
Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancerYehoda M Martei, Kan Chen, Modesty Obasohan, et al.
Journal of Global Oncology|September 23, 2018
Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income CountriesYehoda M Martei, Sebathu Chiyapo, Surbhi Grover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2008
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197Lori J Goldstein, Anne O'Neill, Joseph A Sparano, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumorsL N Shulman, L Buswell, N Riese, et al.
Journal of Oncology Practice|May 2, 2012
US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety StandardsSaul N Weingart, Justin W Li, Junya Zhu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 24, 2012
Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncologySaul N Weingart, Angela Cleary, Bridget Scullion, et al.
Pageof 29

Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
Blood|January 15, 1998
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantationL H Sehn, J H Antin, L N Shulman, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
Oral chemotherapy safety practices at US cancer centres: questionnaire surveySaul N Weingart, Jonathan Flug, Daniela Brouillard, et al.
Journal of the National Cancer Institute|January 1, 2013
Tumor boards and the quality of cancer careNancy L Keating, Mary Beth Landrum, Elizabeth B Lamont, et al.
The American Journal of Medicine|April 1, 1990
Hemostatic complications in young patients with essential thrombocythemiaA J Mitus, T Barbui, L N Shulman, et al.
JNCI Cancer Spectrum|April 25, 2026
Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancerYehoda M Martei, Kan Chen, Modesty Obasohan, et al.
Journal of Global Oncology|September 23, 2018
Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income CountriesYehoda M Martei, Sebathu Chiyapo, Surbhi Grover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2008
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197Lori J Goldstein, Anne O'Neill, Joseph A Sparano, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumorsL N Shulman, L Buswell, N Riese, et al.
Journal of Oncology Practice|May 2, 2012
US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety StandardsSaul N Weingart, Justin W Li, Junya Zhu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 24, 2012
Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncologySaul N Weingart, Angela Cleary, Bridget Scullion, et al.
Pageof 29